REGENXBIO Inc. RGNX
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Luca Issi |
RBC Capital |
8.36 $ |
30 $ |
21.64 % |
07/01/2025 |
| Judah Frommer |
Morgan Stanley |
11.14 $ |
22 $ |
10.86 % |
15/11/2024 |
| Danielle Brill |
Raymond James |
9.185 $ |
18 $ |
8.82 % |
10/10/2024 |
| Yi Chen |
H.C. Wainwright |
11.375 $ |
39 $ |
27.63 % |
05/09/2024 |
| Annabel Samimy |
Stifel Nicolaus |
12.79 $ |
40 $ |
27.21 % |
24/06/2024 |
| Paul Choi |
Goldman Sachs |
13.76 $ |
38 $ |
24.24 % |
07/06/2024 |
| Yi Chen |
H.C. Wainwright |
15.8 $ |
38 $ |
22.20 % |
15/05/2024 |
| Yi Chen |
H.C. Wainwright |
22.85 $ |
36 $ |
13.15 % |
11/03/2024 |
| Luca Issi |
RBC Capital |
22.75 $ |
35 $ |
12.25 % |
08/03/2024 |